From Lumen Bioscience Lands $16M to Engineer “Edible” Antibody Drugs:

Lumen Bioscience
Lumen Bioscience

Lumen Bioscience photo of Jim Roberts (left), co-founder and chief scientific officer and Brian Finrow (right), co-founder and CEO.